Chemotherapy administration codes apply to parenteral administration of non-radionuclide anti-neoplastic drugs
Chemotherapy administration codes apply to parenteral administration of non-radionuclide anti-neoplastic drugs
Chemotherapy administration codes apply to the parenteral administration of non-radionuclide anti-neoplastic drugs, anti-neoplastic agents, or substances such as monoclonal antibody agents, and other biologic response modifiers.
Many of the guidelines updated for 2022 focus on the need to code the diagnosis to the highest level of specificity.